Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Copper
Drug ID BADD_D00529
Description Copper is a transition metal and a trace element in the body. It is important to the function of many enzymes including cytochrome c oxidase, monoamine oxidase and superoxide dismutase [FDA Label]. Copper is commonly used in contraceptive intrauterine devices (IUD) [L801].
Indications and Usage For use in the supplementation of total parenteral nutrition and in contraception with intrauterine devices [FDA Label] [L801].
Marketing Status approved; investigational
ATC Code Not Available
DrugBank ID DB09130
KEGG ID Not Available
MeSH ID D003300
PubChem ID 23978
TTD Drug ID D01WMJ
NDC Product Code 68428-349; 82815-0001; 62106-5020; 51285-204; 0220-1623; 0220-1635; 59365-5128; 68428-140; 64117-958; 0220-1636
UNII 789U1901C5
Synonyms Copper | Copper-63 | Copper 63
Chemical Information
Molecular Formula Cu
CAS Registry Number 7440-50-8
SMILES [Cu]
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Dyschezia07.02.03.005-Not Available
Hydrometra21.10.01.013-Not Available
Haemorrhage24.07.01.002-Not Available
Postmenopausal haemorrhage24.07.03.002; 21.02.01.002-Not Available
Adenomyosis21.07.01.011-Not Available
Endometrial thickening21.07.01.013-Not Available
Food craving19.09.01.010; 14.03.01.009-Not Available
Vulvovaginal pruritus23.03.12.009; 21.08.02.004-Not Available
Dysplasia08.03.04.007-Not Available
Pelvic infection21.10.03.007; 11.01.08.026--
Adnexa uteri pain21.07.04.006-Not Available
Urine output decreased13.13.03.001--
Haemorrhagic ovarian cyst24.07.03.014; 21.11.01.007; 16.04.03.003-Not Available
Adverse event08.06.01.010--Not Available
Inflammation10.02.01.089; 08.01.05.007-Not Available
Perineal pain21.10.01.003-
Complication of pregnancy18.02.02.003-Not Available
Reproductive tract disorder21.10.05.006-Not Available
Sensation of foreign body08.01.09.002-Not Available
Uterine mass21.07.01.012-Not Available
Pregnancy with contraceptive device18.08.01.002; 08.07.04.001-Not Available
Bladder perforation20.03.01.005; 12.02.10.001-
Pelvic discomfort21.10.01.012; 20.02.03.012; 07.01.06.020-Not Available
Complication of device insertion08.07.01.002-Not Available
Coital bleeding21.08.02.015-Not Available
Vulvovaginal burning sensation21.08.02.007-Not Available
Vulvovaginal pain21.08.02.009-
Injury associated with device08.07.01.012; 12.01.08.035-Not Available
Vulvovaginal swelling21.08.02.016-Not Available
Embedded device27.01.01.003--Not Available
The 4th Page    First    Pre   4 5 6    Next   Last    Total 6 Pages
ADReCS-Target
Drug Name ADR Term Target
Tip:  Drug Name  ADR Term  Protein  Variation  Gene